Thomas Edward Adams - 01 Aug 2023 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Role
Chief Financial Officer
Signature
/s/ Stephen Unger, Attorney-in-Fact
Issuer symbol
KRMD
Transactions as of
01 Aug 2023
Net transactions value
$0
Form type
4
Filing time
03 Aug 2023, 17:46:53 UTC
Previous filing
18 Apr 2023
Next filing
30 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRMD Options to Purchase Common Stock Award $0 +100,000 $0.000000 100,000 01 Aug 2023 Common Stock 100,000 $2.54 Direct F2
holding KRMD Options to Purchase Common Stock 200,000 01 Aug 2023 Common Stock 200,000 $3.34 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are subject to a 4 year vesting schedule. 25% of the Shares vest on the 1 year anniversary of the 12/01/2021 date of grant (the "Vesting Commencement Date"), and the remaining Shares vest as follows: 25% of the Shares at the end of each successive 12 month period following the Vesting Commencement Date.
F2 Nonqualified stock options granted pursuant to the Company's 2021 Omnibus Equity Incentive Plan. Options vest in increments of 25,000 on the first anniversary of the date of grant and each anniversary thereafter until fully vested.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.